Recent Transactions

10-Jun-20
Pending
$134 million
Saudi Arabia Flag
Target: 

Equity stake in Bupa Arabia

United Kingdom flag
Acquiror: 
Bupa Ltd.

Advising Bupa, a leading international healthcare group, on the increase of its stake in Bupa Arabia,  the largest health insurance provider in the Kingdom of Saudi Arabia

20-Feb-20
$NA
United Kingdom flag
Target: 

Asia and US rights to Physiogel

Korea flag
Acquiror: 
LG Household & Health Care

Advised GlaxoSmithKline plc (“GSK”), the UK listed international pharmaceutical and consumer healthcare company, on the divestiture of the rights to Physiogel Asia and the US to Korea-based LG Household & Health Care Ltd

16-Jan-20
$NA
Target: 

Daimler's Mercedes-Benz passenger car and private vans distribution operations in Colombia

United Kingdom flag
Acquiror: 
Inchcape PLC

Advised Inchcape, a leading global independent multi-brand automotive distributor, on its acquisition of the Mercedes-Benz passenger car and private vans distribution operations in Colombia from Daimler Colombia

10-Jul-19
$NA
Brazil flag
Target: 

ICC Brazil

Canada flag
Acquiror: 
Lallemand

Advised ICC Brazil, the leader in animal health and nutrition ingredients derived from yeast in Brazil, on establishing a long term strategic partnership with Lallemand, a global leader in the development, production and marketing of yeast, bacteria and specialty ingredients

25-Dec-18
$184 million
Japan flag
Target: 

Hitachi's Automotive Lithium-Ion Battery Business

Japan flag
Acquiror: 
INCJ, Maxell Holdings

Advised Hitachi, a leading global industrial conglomerate, on the sale of its LiB business including Hitachi Vehicle Energy

03-Dec-18
$4.0 billion
United Kingdom flag
Target: 

Assets owned by GlaxoSmithKline plc

Acquiror: 
Unilever plc / Hindustan Unilever Limited

Advised GlaxoSmithKline plc, the UK listed international pharmaceutical and consumer healthcare company, on the divestment of Horlicks and other consumer healthcare nutrition brands to Unilever plc, and on the merger of GSK Consumer Healthcare Limited with Hindustan Unilever Limited

12-Sep-18
$NA
United States flag
Target: 

Uniseal, Inc.

Korea flag
Acquiror: 
LG Chem Ltd.

Advised LG Chem, a global diversified chemicals manufacturer based in South Korea, on the acquisition of Uniseal, a U.S.-based supplier of sealants and adhesives to leading automotive manufacturers

21-Aug-18
$171 million
Japan flag
Target: 

Nihon Nohyaku Co., Ltd.

Japan flag
Acquiror: 
ADEKA Corporation

Advised ADEKA Corporation, a global chemical manufacturer, on the acquisition of 51% stake of Nihon Nohyaku via the combination of the Tender Offer and Capital Injection

31-Jul-18
$NA
Argentina flag
Target: 

PLA S.A.

United States flag
Acquiror: 
Deere & Co.

Advised PLA S.A, an Argentina-based manufacturer of agricultural machinery, on its sale to Deere & Co.

25-Jul-18
$145 million
United States flag
Target: 

Park Electrochemical (Electronics Business)

Japan flag
Acquiror: 
AGC Inc.

Advised Park Electrochemical, a leading high-performance electronics materials manufacturer, on the sale of its Electronics Business to AGC Inc.

22-Jul-18
$NA
Brazil flag
Target: 

Cura Imagem e Diagnóstico Ltda.

Brazil flag
Acquiror: 
Vinci Partners

Advised Cura, a leading independent provider of diagnostic imaging (MRI, CT, etc.) and other clinical analysis services on the sale of 70% of its stake to the PE fund Vinci Partners

25-Jun-18
Pending
$NA
Brazil flag
Target: 

Cura Imagem e Diagnóstico Ltda.

Brazil flag
Acquiror: 
Vinci Partners

Advising Cura, a leading independent provider of diagnostic imaging (MRI, CT, etc.) and other clinical analysis services on the sale of 70% of its stake to the PE fund Vinci Partners

23-Apr-18
$NA
Colombia flag
Target: 

Grupo Proenfar

Netherlands flag
Acquiror: 
Weener Plastics

Advised Grupo Proenfar, a Colombia-based plastics packaging solutions provider, and its shareholders on its sale to Weener Plastics

30-Nov-17
$NA
Germany flag
Target: 

MorphoSys AG

China flag
Acquiror: 
I-Mab

Advised MorphoSys AG, a German biopharmaceutical company, on a regional licensing agreement covering Greater China and comprising its investigational anti-CD38 antibody MOR202 targeting multiple myeloma, with I-Mab

01-Aug-17
$NA
Brazil flag
Target: 

Deltaplam

United States flag
Acquiror: 
Sealed Air Corporation

Advised Deltaplam, a Brazilian flexible packaging manufacturer, on its 100% sale to Sealed Air Corporation, a global provider of knowledge-based food, product and medical packaging solutions

18-Jul-17
$NA
Brazil flag
Target: 

Radiogroup Participações S.A.

Brazil flag
Acquiror: 
Grupo Oncoclínicas

Advised Radiogroup, a regional leader in cancer treatment through radiotherapy, on its sale of a majority stake to Grupo Oncoclínicas

14-Jul-17
$775 million
Australia flag
Target: 

Programmed Maintenance Services Limited

Japan flag
Acquiror: 
PERSOL HOLDINGS CO LTD.

Advised PERSOL HOLDINGS, one of Japan’s largest HR service companies, on its acquisition of ASX-listed Programmed Maintenance Services, a leading Australian and New Zealand based provider of staffing and maintenance services

03-Apr-17
$205 million
Australia flag
Target: 

Inenco Group Pty Ltd

United States flag
Acquiror: 
Genuine Parts Company

Advised Inenco Group Pty Ltd, one of Australasia’s leading industrial distributors, on the partial sale to Genuine Parts Company, a global distributor of automotive and industrial products

05-Oct-16
$775 million
U.K., Ireland flags
Target: 

Assets and operations of Actavis Generics in the UK and Ireland from Teva Pharmaceutical Industries Ltd.

India flag
Acquiror: 
Accord Healthcare Ltd.

Advised Teva Pharmaceutical Industries Ltd., the world’s largest generic drug company, on its sale of assets and operations of Actavis Generics in the UK and Ireland to Accord Healthcare Ltd. (a subsidiary of Intas Pharmaceuticals Limited) for £603m (c.$775m) 

05-Oct-16
$NA
Israel flag
Target: 

Portfolio of 14 Outlicensing generic products in the EEA from Teva Pharmaceutical Industries Ltd.

India flag
Acquiror: 
Accord Healthcare Ltd.

Advised Teva Pharmaceutical Industries Ltd., the world’s largest generic drug company, on the divestment of a portfolio of 14 Outlicensing pharmaceutical products in the EEA to Accord Healthcare Ltd. (a subsidiary of Intas Pharmaceuticals Limited).

20-Jun-16
$NA
Israel flag
Target: 

U.S. rights to 2 generic drug products from Teva Pharmaceutical Industries Ltd.

India flag
Acquiror: 
Zydus Cadila

Advised Teva Pharmaceutical Industries Ltd. on the divestment of the U.S. rights to 2 generic drug products to Zydus Cadila

11-Jun-16
$350 million
Israel flag
Target: 

U.S. rights to 8 generic drug products from Teva Pharmaceutical Industries Ltd.

India flag
Acquiror: 
Dr. Reddy’s Laboratories

Advised Teva Pharmaceutical Industries Ltd. on the divestment of the U.S. rights to 8 generic drug products to Dr. Reddy’s Laboratories

18-Mar-16
$NA
China flag
Target: 

Sewells Group

United States flag
Acquiror: 
MSX International

Advised WorldMark on the sale of Sewells Group to MSX International, a global provider of outsourced business solutions.  Sewells, headquartered in Shanghai, is a leading provider of automotive dealership development services across Asia Pacific, Africa and the Middle East

19-Jan-16
$NA
Brazil flag
Target: 

Recepta Biopharma

Brazil flag
Acquiror: 
Inova Empresa Fundo de Investimento em Participações

Advised Recepta Biopharma on a capital raise

20-Aug-15
$1.0 billion
China flag
Target: 

COOEC Fluor Heavy Industries Co., Ltd.

United States flag
Acquiror: 
Fluor Corporation

Advised Fluor Corporation on its $489 million investment for a 49% interest in a joint venture with Offshore Oil Engineering Co., Ltd. (COOEC) to own, operate and manage the Zhuhai Fabrication Yard in China’s Guangdong province

Pages

show all